KORU Medical Systems to Participate in Upcoming Investor Conferences
2023年11月3日 - 5:05AM
ビジネスワイヤ(英語)
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on the
development, manufacturing, and commercialization of innovative and
easy-to-use subcutaneous drug delivery systems that improve quality
of life for patients, today announced that the Company will
participate in two upcoming investor conferences.
KORU Medical's management is participating at the Canaccord
MedTech, Diagnostics and Digital Health & Services Forum on
Thursday, November 16th, 2023.
KORU Medical's management will also be participating at the 14th
Annual Craig-Hallum Alpha Select Conference on Thursday, November
16th, 2023.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous drug delivery systems that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and
FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™
and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102149761/en/
Investor Contact: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
過去 株価チャート
から 4 2024 まで 5 2024
KORU Medical Systems (NASDAQ:KRMD)
過去 株価チャート
から 5 2023 まで 5 2024